Serum chitotriosidase activity in gaucher patients on enzyme replacement therapy (ERT)

Clinical Biochemistry

Volumn 31, Issue 5, 1998, Pages 417-420

  Czartoryska, Barbara ^a   Tylki Szymańska, Anna ^b   Górska, Danuta ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Ceredase ; Chitotriosidase; Enzyme replacement therapy (ERT); Gaucher

Indexed keywords

ALGLUCERASE; CHITOSANASE; HYMECROMONE; TRIOSE;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CHILD; FEMALE; FOLLOW-UP STUDIES; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HEMOGLOBINS; HEXOSAMINIDASES; HUMANS; INDICATORS AND REAGENTS; MALE; PLATELET COUNT; REFERENCE VALUES; SPECTROMETRY, FLUORESCENCE; SPLENECTOMY; TIME FACTORS;

EID: 0032128216     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00030-7     Document Type: Conference Paper

References (11)

1. Beutler E., Grabowski G.A. Gaucher disease. Scriver C.R., Beaudet A.L., Sly W.S. The Metabolic and molecular bases of inherited disease. 10th ed. 1995;2641-2670 McGraw-Hill, New York.
2. Hollak C.E., van Weely S., van Oerts M.H., Aerts J.M. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 93:1994;1288-1292.
3. Guo Y., He W., Boer A.M., Wevers R.A., et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inher Metab Dis. 18:1995;717-722.
4. Renkema G.H., Boot R.G., Muijsers A.O., Donker-Koopman W.E., Aerts J.M. Purification and characterisation of human chitotriosidase, a novel member of chitinase family of proteins. J Biol Chem. 270:1995;2198-2202.
5. Boot R.G., Renkema G.H., Strijland A., van Zonneveld A.J., Aerts J.M. Cloning of cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem. 270:1995;26252-26256.
6. Barton N.W., Firbish F.S., Murray G.J., Garfield M., Brady R.O. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA. 87:1990;1913-1916.
7. Barton W.N., Brady R.O., Dambrosia J.M. Replacement therapy for inherited enzyme deficiency - macrophage target glucocerebrosidase for Gaucher disease. N Engl J Med. 324:1991;1464-1470.
8. Young E., Chaterton C., Vellodi A., Winchester B. Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or enzyme replacement therapy with alglucerase. J Inher Metabol Dis. 20:1997;595-602.
9. Beutler E., Demina A., Laubscher K., et al. The clinical course of treated and untreated Gaucher disease. A study of 4 patients. Blood-Cells Mol Dis. 21:1995;86-108.
10. Mistry P.K., Wraight E.P., Cox T.M. Therapeutic delivery of proteins to macrophages implications for treatment of Gaucher disease . Lancet. 348:1996;1555-1559.
11. Sato Y., Beutler E. Binding, internalization and degradation of mannose-terminated glucocerebrosidase by macrophages. J Clin Invest. 91:1993;1909-1917.